|
Since time immemorial
humans have used
entheogens and other psychoactive drugs as
integral tools for achieving insight and epistemological understanding, and
to enter modes of thought conducive to physical and psychological healing.
The work of many respected intellectuals, writers and artists has been
influenced and inspired by the use of drugs that today are classified as
illegal “controlled substances.” Today, worldwide, hundreds of thousands
of people use MDMA (Ecstasy) and other modern cognitive
enhancers in conjunction with ecstatic Rave
dances, and as adjuncts to psychotherapy and self-analysis.
As
part of the CCLE's mission to foster cognitive liberty, the CCLE has
developed the Entheogen and Drug Policy Project to encourage public
education and policy reform with regard to entheogens and other psychoactive
drugs. National and international drug policy should accommodate otherwise
law-abiding citizens who use these substances without harming others.
At bottom, the CCLE maintains that the criminalizing of peaceful people who
use psychoactive drugs is a real and present encroachment upon cognitive
liberty. The CCLE calls for a reevaluation of the so-called “drug war,”
and works to reframe the public debate to emphasize the important cognitive
liberty principles and rights that are presently at stake.
The
CCLE’s
Entheogen
and Drug Policy Project
works to:
1)
Interject the principle of cognitive liberty into the public debate about
drug policy.
2)
Produce policy analysis and provide written and spoken testimony concerning
proposed drug-related legislation, administrative actions, and court
decisions, highlighting the cognitive liberty aspects of the item under
review.
3)
Support litigation in precedent setting legal cases concerning entheogens
and other drugs.
4)
Coordinate with our William
James Project as well as our Neuroethics
Project to address common issues.
5)
Encourage scholarly and broader organizational awareness of the impact that
the “war on drugs” has on freedom of thought.
Return to Entheogen
and Drug Policy Project Index
|
